Massachusetts House Bill H927

Massachusetts 2023-2024 Regular Session

• Introduced: 2/16/23
• Refer: 2/16/23
• Refer: 2/22/24

Caption

Relative to colon cancer screening

Impact

Should H927 be enacted, it would amend several chapters of the General Laws to expand coverage mandates associated with colorectal cancer screenings across the state. This includes not only state employees but also private insurance policies, promoting a comprehensive approach to health care equity. The requirement for insurers to provide these screenings without co-payments or deductibles aims to eliminate financial barriers, thereby encouraging individuals to get screened routinely.

Summary

House Bill 927 aims to enhance colorectal cancer prevention by mandating coverage for screening services starting at 30 years of age. This legislation seeks to ensure that various screening methods, including flexible sigmoidoscopy, FIT tests, and colonoscopies, are deemed medically necessary by a patient's primary care physician and are covered without cost-sharing requirements. This initiative is intended to promote early detection and improve health outcomes among residents of the Commonwealth by ensuring equitable access to essential preventive services.

Contention

As with many health-related legislative initiatives, there may be contention among various stakeholders regarding funding, the efficacy of preventive measures, and broader implications for health policy. Supporters argue that extending coverage for these essential screenings represents a critical public health strategy that will save lives through early detection. However, some critics may raise concerns about the financial impact on health insurers and the potential for incentivizing unnecessary medical services, necessitating a balanced discussion surrounding health care costs versus benefits.